ARTICLES

wakix logo
Pharmacological Narcolepsy

FDA Expands Use Of WAKIX For Cataplexy

Harmony Biosciences Holdings, Inc. announced the FDA has approved WAKIX® (pitolisant) for the treatment of cataplexy in adult patients with narcolepsy. WAKIX is the first and only treatment approved by the FDA for people with excessive daytime sleepiness or cataplexy associated with narcolepsy that is not scheduled as a controlled […]

masimo ori
Sleep Disorders

Masimo ORi Can Predict Need for Postoperative O2 Therapy in Peds with OSA

Masimo announced the findings of an abstract recently presented at ANESTHESIOLOGY® 2020, the Annual Meeting of the American Society of Anesthesiologists (ASA). In this independent, retrospective study, researchers investigated whether Masimo ORi™ (Oxygen Reserve Index) could predict whether children with obstructive sleep apnea syndrome (OSAS) undergoing tonsillectomy required postoperative oxygen therapy. […]

mouse
Research & Studies

Study Finds Gut Microbiome Plays Important Role in Sleep Regulation

Transplanted bacteria from sleep-apnea mice caused sleep changes in recipient mice  Evidence suggests OSA can alter the gut microbiome (GM) and may promote OSA-associated co-morbidities, including diabetes, hypertension, and cognitive problems. Researchers from the University of Missouri School of Medicine and MU Health Care have discovered how OSA-related sleep disturbances affect the gut microbiome in mice […]

cystic fibrosis lungs
Pediatric Health Pharmacological

FDA Grants SPIRO-2101 CF Treatment Orphan Drug and Rare Pediatric Disease Designations 

Spirovant Sciences, a gene therapy company developing treatments and cures for genetic lung diseases including cystic fibrosis, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Rare Pediatric Disease Designations to its lead product candidate, SPIRO-2101, for the treatment of cystic fibrosis. SPIRO-2101, an inhaled […]

Teva Launches Two Digital Powder Inhalers in the U.S.
Pharmacological

Teva Launches Two Digital Powder Inhalers in the U.S.

Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of AirDuo® Digihaler® (fluticasone propionate and salmeterol) inhalation powder and ArmonAir® Digihaler® (fluticasone propionate) inhalation powder, two digital maintenance inhalers for patients with asthma. AirDuo® Digihaler® is a prescription medicine used to control symptoms of asthma and to prevent symptoms such as […]